OBT-893

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameOBT-893
Drug Alias NameOBT-893SH-BC-893
ClassificationSmall molecules
Mechanisms of ActionProtein phosphatase 2A stimulantsSphingosine 1-phosphate receptor 5 agonists
TargetsProtein phosphatase 2ASphingosine 1-phosphate receptor 5
Therapy Area/IndicationsHormone-Resistant Prostate NeoplasmsPancreatic NeoplasmsColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesObsidio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesObsidio Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHormone-Resistant Prostate NeoplasmsPancreatic NeoplasmsColorectal Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A